Fut, nem toboroz3. fázis
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
A legfontosabb adatok
- Ki végzi
- Clinuvel, Inc.
- Hol
- Alpharetta, Augusta, Baton Rouge, Birmingham, Cedar Park, Charleston, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Fresno, Lee's Summit, Los Angeles, Miami, Minneapolis, Miramar, Palo Alto, Philadelphia, Rochester, Roseville, San Diego, Thompson's Station, Tyler és Washington D.C. (Egyesült Államok)Mind a 25 helyszín megnézéseMég 4 másik országban, 6 helyszínen
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 3. fázis
- Résztvevők
- 200 fő, tervezett
- Kezdés
- 2023. okt. 11.
- Befejezés
- 2026. jún.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Afamelanotide and NB-UVB Light
- NB-UVB Light
- A regiszteradat frissítve
- 2025. július 8.
Ki vehet részt
- Életkor
- 12 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter összes feltétele (18)A regiszter feltételeinek elrejtése
Ki vehet részt
- Male and female patients with a confirmed diagnosis of generalized vitiligo with VASI≥3 of the body and VASI on the head and neck ≥0.3 including an F-VASI≥0.1
- Stable or active vitiligo
- Aged 12 or more
- Fitzpatrick skin types III-VI
Ki nem vehet részt
- Treatment with NB-UVB phototherapy in the last three months prior to study start
- Any other treatment for vitiligo within 30 days prior to the Screening Visit
- Use of any prior and concomitant therapy which may interfere with the objective of the study
- Allergy to afamelanotide or the polymer contained in the implant
- History of melanoma or lentigo maligna
- History of dysplastic nevus syndrome
- Any malignant skin lesions
- Presence of severe hepatic disease or hepatic impairment
- Fitzpatrick skin types I-II
- Extensive leukotrichia
- Female who is pregnant or lactating
- Female of child-bearing potential not using adequate contraceptive measures
- Sexually active man with a partner of child-bearing potential who is not using adequate contraceptive measures
- Extensive tattoos
Helyszínek itt: Egyesült Államok
Még 4 másik országban, 6 helyszínen
- Alpharetta, GeorgiaHospital not named in the registry
- Augusta, GeorgiaHospital not named in the registry
- Baton Rouge, LouisianaHospital not named in the registry
- Birmingham, AlabamaHospital not named in the registry
- Cedar Park, TexasHospital not named in the registry
- Charleston, South CarolinaHospital not named in the registry
- Charlottesville, VirginiaHospital not named in the registry
- Chicago, IllinoisHospital not named in the registry
- Cleveland, OhioHospital not named in the registry
- Dallas, TexasHospital not named in the registry
- Detroit, MichiganHospital not named in the registry
- Fresno, CaliforniaHospital not named in the registry
- Lee's Summit, MissouriHospital not named in the registry
- Los Angeles, CaliforniaHospital not named in the registry
- Miami, FloridaHospital not named in the registry
- Minneapolis, MinnesotaHospital not named in the registry
- Miramar, FloridaHospital not named in the registry
- Palo Alto, CaliforniaHospital not named in the registry
- Philadelphia, PennsylvaniaHospital not named in the registry
- Rochester, New YorkHospital not named in the registry
- Roseville, MinnesotaHospital not named in the registry
- San Diego, CaliforniaHospital not named in the registry
- Thompson's Station, TennesseeHospital not named in the registry
- Tyler, TexasHospital not named in the registry
- Washington D.C., District of ColumbiaHospital not named in the registry
A vizsgálatról
Mit akar kideríteni a vizsgálat
The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.
A vizsgálat 2 csoportja
- Afamelanotide and NB-UVB LightA vizsgált kezelés
- NB-UVB LightEgyéb csoport
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on és az EU hivatalos vizsgálati nyilvántartásában (CTIS).
- Hivatalos cím
- A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo
- A regiszteradat frissítve
- 2025. július 8.